We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+12.29%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$860M
AUM Growth
+$40M
Cap. Flow
-$31.5M
Cap. Flow %
-3.66%
Top 10 Hldgs %
15.16%
Holding
490
New
45
Increased
74
Reduced
170
Closed
70

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$9.17M
2
T icon
AT&T
T
+$5.26M
3
NOVA
Sunnova Energy
NOVA
+$4.56M
4
AMN icon
AMN Healthcare
AMN
+$3.98M
5
EVR icon
Evercore
EVR
+$3.95M

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Healthcare 16.83%
3 Industrials 13.83%
4 Consumer Discretionary 11.1%
5 Materials 10.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGNX icon
26
Cognex
CGNX
$10.2B
$6.87M 0.8%
81,775
-2,411
-3% -$195K
XOM icon
27
ExxonMobil
XOM
$657B
$6.64M 0.77%
+105,285
New +$6.29M
ERII icon
28
Energy Recovery
ERII
$397M
$6.47M 0.75%
284,244
-93,139
-25% -$1.84M
JPM icon
29
JPMorgan Chase
JPM
$971B
$6.27M 0.73%
40,329
+12,152
+43% +$1.91M
ITI
30
DELISTED
Iteris, Inc.
ITI
$6.25M 0.73%
940,107
+27,230
+3% +$184K
CDMO
31
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$6.11M 0.71%
238,236
+13,378
+6% +$286K
NFLX icon
32
Netflix
NFLX
$309B
$6M 0.7%
113,530
-7,350
-6% -$376K
CIEN icon
33
Ciena
CIEN
$61.2B
$5.95M 0.69%
104,495
+50,192
+92% +$2.77M
TWST icon
34
Twist Bioscience
TWST
$7.85B
$5.8M 0.67%
43,525
-8,718
-17% -$1.01M
RAVN
35
DELISTED
Raven Industries Inc
RAVN
$5.8M 0.67%
100,225
-517
-0.5% -$22.5K
INVE icon
36
Identive
INVE
$63.4M
$5.76M 0.67%
338,711
-29,547
-8% -$446K
PFE icon
37
Pfizer
PFE
$150B
$5.75M 0.67%
146,900
+66,203
+82% +$2.57M
WMT icon
38
Walmart Inc
WMT
$923B
$5.73M 0.67%
121,887
-27,537
-18% -$1.28M
AEM icon
39
Agnico Eagle Mines
AEM
$93.8B
$5.7M 0.66%
94,220
-10,187
-10% -$680K
CAT icon
40
Caterpillar
CAT
$393B
$5.6M 0.65%
25,740
-1,686
-6% -$389K
ST icon
41
Sensata Technologies
ST
$6.72B
$5.51M 0.64%
95,104
-7,450
-7% -$434K
CRSP icon
42
CRISPR Therapeutics
CRSP
$5.22B
$5.48M 0.64%
33,836
-1,704
-5% -$207K
IIPR icon
43
Innovative Industrial Properties
IIPR
$1.67B
$5.46M 0.63%
28,567
-2,045
-7% -$375K
DAVA icon
44
Endava
DAVA
$162M
$5.12M 0.6%
45,156
-9,954
-18% -$963K
VCYT icon
45
Veracyte
VCYT
$3.59B
$5.08M 0.59%
127,011
+9,948
+8% +$425K
DDD icon
46
3D Systems Corp
DDD
$603M
$5.04M 0.59%
+126,142
New +$3.33M
STKL
47
DELISTED
SunOpta
STKL
$5.04M 0.59%
411,642
-53,032
-11% -$692K
CDXS icon
48
Codexis
CDXS
$175M
$4.97M 0.58%
219,311
-13,869
-6% -$301K
DKNG icon
49
DraftKings
DKNG
$12.7B
$4.96M 0.58%
95,035
-10,287
-10% -$543K
B
50
Barrick Mining
B
$67.9B
$4.9M 0.57%
236,995
+40,369
+21% +$910K

Similar funds

Essex Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Essex Investment Management held 490 positions worth $860M, up 4.9% from $820M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Essex Investment Management withdrew a net $31.5M in Q2 2021, closing 70 positions and reducing 170 holdings. Its most notable exit was Freeport-McMoran, an estimated $9.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Essex Investment Management opened a new position in ExxonMobil worth $6.64M.

  • Essex Investment Management's largest Q2 2021 buy was ExxonMobil: 105,285 shares worth $6.64M.
  • Essex Investment Management added most to Evoqua Water Technologies Corp. Common Stock in Q2 2021, an estimated $4.54M increase.
  • Essex Investment Management's biggest Q2 2021 reduction was AT&T, cutting an estimated $5.26M.
  • Essex Investment Management fully exited Freeport-McMoran in Q2 2021, selling an estimated $9.17M.
  • Essex Investment Management's ten largest holdings make up 15% of its $860M portfolio in Q2 2021.
  • Essex Investment Management opened 45 new positions and closed 70 in Q2 2021.
  • Essex Investment Management's portfolio value rose 4.9% quarter-over-quarter to $860M.

Based on Essex Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.